cheap jersey knit fabric Big pharma spots potential of Cambridge disease breathalyzer

cheap buffalo bills jerseys Big pharma spots potential of Cambridge disease breathalyzer

Get daily updates directly to your inbox+ SubscribeThank you for subscribing!The breath biopsy platform devised by Owlstone Medical is being used by GSK in the clinical development programme of danirixin, one of the novel drug candidates in its respiratory disease pipeline.My anger about my wife’s death fuels my battle to save other cancer victimsOwlstone says the deal with GSK is a further important step in Owlstone Medical’s strategy to build a significant precision medicine business based on the platform, which analyses biomarkers from breath and has the potential to generate data needed to improve clinical outcomes and reduce healthcare costs.Owlstone Medical’s CE marked ReCIVA Breath SamplerBilly Boyle, co founder and CEO at Owlstone Medical, said: “We are very pleased to work with GSK as they lead the way in using breath VOC profiling to better understand a new drug’s treatment effects and its mechanism. Our growing precision medicine business not only provides opportunities for near term revenue expansion, but also deepens the pipeline of applications for Breath Biopsy.”We believe that the non invasive breath biopsy can rapidly establish a central role in a variety of precision medicine applications such as patient stratification and monitoring treatment response. We intend to work with multiple pharmaceutical partners looking to optimize the health economic impact of their new medicines across a broad range of diseases by providing access to the data needed to ensure that the right therapy is given to the right patient at the right time.”Billy Boyle, co founder and CEO at Owlstone Medical, demonstrates the ReCIVA Breath SamplerGSK will use the platform as part of a Phase II clinical trial to assess whether the right patient for the right treatment can be identified, as well as assessing the treatment effects of a novel drug for chronic obstructive pulmonary disease (COPD). The platform will be used to capture Volatile Organic Compounds (VOCs) in breath completely non invasively, and analyse them with high sensitivity. The breath samples will be collected from patients participating in the clinical trial using Owlstone Medical’s CE marked ReCIVA Breath Sampler,
cheap jersey knit fabric Big pharma spots potential of Cambridge disease breathalyzer
before shipping to the company’s clinical lab for analysis.Cambridge innovation on display at London’s Science MuseumEach exhaled breath contains a rich spectrum of VOCs produced by the body’s metabolism that relate directly to disease activity, and when analyzed can provide important insights for patient stratification. In addition, a patient’s VOC profile in breath can be modified by introducing external factors including therapeutic interventions, which on analysis could also provide valuable information about the therapeutic effects of the drug being assessed.Dr. Ruth Tal Singer, VP, Medicine Development Leader and GSK Senior Fellow, Respiratory R GSK, said: “As part of our efforts to identify the right patient for the right treatment, we are pleased to include Breath Biopsy for the first time in one of our clinical trials. We hope that exploration of volatile compounds in breath will provide a tool to identify COPD patients who could benefit most from our medicines. We look forward to analyzing the results generated from Breath Biopsy when available.”Like us on FacebookFollow us on TwitterDaily NewsletterA14Dangerous A14 markings to be changed two days after the News reported on themHighways England will be closing the eastbound carriageway between junction 26 and junction 31 tonightChristmasCambridge and South Cambridgeshire Christmas and New Year bin collection dates 2017Changes to the usual bin collection dates over Christmas and New YearTraffic TravelTraffic and travel live: A14 delays after emergency repairsTraffic and travel live reporting on major roads, including the A14, M11 and A1,
cheap jersey knit fabric Big pharma spots potential of Cambridge disease breathalyzer
that might affect your routeCambridge United FCCambridge United coach departs for Coventry CityThe first team coach only arrived at The Abbey in JanuaryCambridge Science ParkCambridge electronics lab set to close with 40 jobs reportedly axedWorkers say they have been told the research facility will close in March next year